- Supported exchanges /
- SHE /
- 300030.SHE
Guangzhou Improve Med Instrument (300030 SHE) stock market data APIs
Improve Medical Instruments Co., Ltd. engages in the provision of relevant technologies, products, and services for clinical laboratory and clinical nursing in China and internationally. It provides clinical laboratory products comprising urine, feces, and thrombosis viscoelastic analysis systems; and automatic biosafety decappers; and Q-VELOX, an intelligent molecular diagnostic workstation. The company also offers offers specimen processing equipment, including evacuated blood collection systems, evacuated blood collection tubes, multi-sample needles, blood collection sets, tourniquets and disposable tourniquets, urine collection systems, and holders under IMPROVACUTER brand name; and IMPROMINI capillary blood collection systems, IMPROSWAB microbiological transportation systems, IMPRONURSE infusion pumps and syringe pumps, LONGX urine analysis systems, in-vitro diagnostic reagents, IMPROSAFE safety blood collection needles, IMPROSWAB microbiological transport swabs, IMPROVE sharps containers, liquid biopsy pre-analytical systems, etc. In addition, it provides clinical nursing products, including automatic, handheld, pulsewave, and smart wireless blood pressure monitors; and intelligent management solutions, such as blood collection tube preparation systems, friendly graphic user interfaces, intelligent sorters, multi-function blood collection tables, intelligent queue systems, urine collection tube preparation systems, automatic tube packer systems, and consumable labels, as well as CryoMax vials and liquid nitrogen freezing storage boxes. The company was formerly known as Guangzhou Improve Medical Instruments Co., Ltd. Improve Medical Instruments Co., Ltd. was founded in 1996 and is headquartered in Guangzhou, China.
Guangzhou Improve Med Instrument Financial Data Overview
| 6.41 | |
| 6.66 | |
| - | |
| 6.86 | |
| 6.37 | |
| 3.31-8.6 | |
| 1 982 M | |
| 309 M | |
| 594 M | |
| -0.1205 | |
| 0.377 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Guangzhou Improve Med Instrument Fundamental Data is available in our Financial Data APIs
- Net Revenue 594 M
- EBITDA 3 922 K
- Earnings Per Share -0.35
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Guangzhou Improve Med Instrument Earnings via APIs
- Latest Release 2024-10-26
- EPS/Forecast NaN
Get Guangzhou Improve Med Instrument End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
